Recall: GlaxoSmithKline Drug Packaged In Nebraska

Posted on

According to news sources, a recall has recently been announced by GlaxoSmithKline for a drug packaged in Nebraska. The recall affects about 400,000 bottles of a blood pressure drug called DynaCirc CR, which was packaged in Nebraska at a Novartis plant.

The plant is reportedly manufacturing the generic drug on a contract basis. There have been no reported contamination complaints or tablet mix-ups to date in association with the recalled drug. The recall was reportedly issued after the Food and Drug Administration voiced “compliance concerns” regarding the packaging process of the generic drug.

The recall is the second one to be issued by the company for drugs manufactured at the same plant during this year. The plant was also temporarily shut down in mid-December due to an FDA investigation.

As a Los Angeles Personal Injury Lawyer, I appreciate all efforts being made to ensure increased drug safety standards and encourage consumers to learn more about the potential risks associated with similar product recalls. If you or a loved one has been injured through the use or consumption of a defective product, speak with a personal injury lawyer San Bernardino learn about the legal options available to you.